Document:

Exelis Inc. Special Senior Executive Severance Pay Plan

 Exhibit 10.35 
 Exelis Inc. 
 Special Senior Executive Severance Pay Plan 

 

	1.	Purpose 

 The purpose of this
Exelis Inc. Special Senior Executive Severance Pay Plan (“Plan”) is to assist in occupational transition by providing Severance Benefits, as defined herein, for employees covered by this Plan whose employment is terminated under conditions
set forth in this Plan. 
 The Plan first became effective as of October 31, 2011 following the spin-off of Exelis Inc.
from ITT Corporation (the “Predecessor Corporation”) on October 31, 2011. The Predecessor Corporation maintained a similar plan prior to the spin-off (the “Predecessor Plan”), and the Plan was created to continue service
accruals under the Predecessor Plan. The Plan shall remain in effect as provided in Section 9 hereof, and covered employees shall receive full credit for their service and participation with the Predecessor Corporation as provided in
Section 5 hereof. 
  

	2.	Covered Employees 

 Covered
employees under this Plan (“Special Severance Executives”) are active full-time, regular salaried employees of Exelis Inc., (“Exelis”) and of any subsidiary company (“Exelis Subsidiary”) (collectively or individually as
the context requires “Company” ; provided, however, that for purposes of service under the Predecessor Plan, Company shall include the Predecessor Corporation) (including Special Severance Executives who are short term disabled as of a
Potential Acceleration Event within the meaning of the Company’s short term disability plans) (other than Special Severance Executives on periodic severance as of a Potential Acceleration Event) who are in Band A or B or were in Band A or B at
any time within the two year period immediately preceding an Acceleration Event and such other employees of the Company who shall be designated as covered employees in Band A or B under the Plan by the Compensation and Personnel Committee of
Exelis’ Board of Directors. 
 “Bands A and B” shall have the meaning given such terms under the executive
classification system of the Exelis Human Resources Department as in effect immediately preceding an Acceleration Event. After the occurrence of an Acceleration Event, the terms “Exelis”, “Exelis Subsidiary” and
“Company” as used herein shall also include, respectively and as the context requires, any successor company to Exelis or any successor company to any Exelis Subsidiary and any affiliate of any such successor company. 

 

	3.	Definitions 

 An
“Acceleration Event” shall occur if (i) a report on Schedule 13D shall be filed with the Securities and Exchange Commission pursuant to Section 13(d) of the Securities Exchange Act of 1934 (the “Act”) disclosing that
any person (within the meaning of Section 13(d) of the Act), other than the Company or a subsidiary of the Company or any employee benefit plan 

 
sponsored by the Company or a subsidiary of the Company, is the beneficial owner directly or indirectly of twenty percent (20%) or more of the outstanding Common Stock $1 par value, of the
Company (the “Stock”); (ii) any person (within the meaning of Section 13(d) of the Act), other than the Company or a subsidiary of the Company, or any employee benefit plan sponsored by the Company or a subsidiary of the Company,
shall purchase shares pursuant to a tender offer or exchange offer to acquire any Stock of the Company (or securities convertible into Stock) for cash, securities or any other consideration, provided that after consummation of the offer, the person
in question is the beneficial owner (as such term is defined in Rule 13d-3 under the Act), directly or indirectly, of twenty percent (20%) or more of the outstanding Stock of the Company (calculated as provided in paragraph (d) of Rule
13d-3 under the Act in the case of rights to acquire Stock); (iii) the consummation of (A) any consolidation, business combination or merger involving the Company, other than a consolidation, business combination or merger involving the
Company in which holders of Stock immediately prior to the consolidation, business combination or merger (x) hold fifty percent (50%) or more of the combined voting power of the Company (or the corporation resulting from the merger or
consolidation or the parent of such corporation) after the merger and (y) have the same proportionate ownership of common stock of the Company (or the corporation resulting from the merger or consolidation or the parent of such corporation),
relative to other holders of Stock immediately prior to the merger, business combination or consolidation, immediately after the merger as immediately before, or (B) any sale, lease, exchange or other transfer (in one transaction or a series of
related transactions) of all or substantially all the assets of the Company, (iv) there shall have been a change in a majority of the members of the Board of Directors of the Company within a 12-month period unless the election or nomination
for election by the Company’s stockholders of each new director during such 12-month period was approved by the vote of two-thirds of the directors then still in office who (x) were directors at the beginning of such 12-month period or
(y) whose nomination for election or election as directors was recommended or approved by a majority of the directors who were directors at the beginning of such 12-month period or (v) any person (within the meaning of Section 13(d)
of the Act) (other than the Company or any subsidiary of the Company or any employee benefit plan (or related trust) sponsored by the Company or a subsidiary of the Company) becomes the beneficial owner (as such term is defined in Rule 13d-3 under
the Act) of twenty percent (20%) or more of the Stock. 
 “Cause” shall mean action by the Special Severance
Executive involving willful malfeasance or gross negligence or the Special Severance Executive’s failure to act involving material nonfeasance that would tend to have a materially adverse effect on the Company. No act or omission on the part of
the Special Severance Executive shall be considered “willful” unless it is done or omitted in bad faith or without reasonable belief that the action or omission was in the best interests of the Company. 

“Good Reason” shall mean (i) without the Special Severance Executive’s express written consent and excluding for this
purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company or its affiliates within 30 days after receipt of notice thereof given by the Special Severance Executive, (A) a reduction in
the Special Severance Executive’s annual base compensation (whether or not deferred), (B) the assignment to the Special Severance Executive of any duties inconsistent in any material respect with the Special Severance Executive’s
position (including status, offices, titles and reporting requirements), authority, duties or responsibilities, or (C) any other action by the Company or its 

  
 2 

 
affiliates which results in a material diminution in such position, authority, duties or responsibilities; (ii) without the Special Severance Executive’s express written consent, the
Company’s requiring the Special Severance Executive’s work location to be other than within twenty-five (25) miles of the location where such Special Severance Executive was principally working immediately prior to the Acceleration
Event; or (iii) any failure by the Company to obtain the express written assumption of this Plan from any successor to the Company; provided that “Good Reason” shall cease to exist for an event on the 90th day following the later of
its occurrence or the Special Severance Executive’s knowledge thereof, unless the Special Severance Executive has given the Company notice thereof prior to such date. 
 “Potential Acceleration Event” shall mean any execution of an agreement, the commencement of a tender offer or any other transaction or event that if consummated would result in an Acceleration
Event. 
  

	4.	Severance Benefits Upon Termination of Employment 

 If, a Special Severance Executive’s employment with the Company is terminated due to a Qualifying Termination, he or she shall receive the severance benefits set forth in Section 5 hereof
(“Severance Benefits”). For purposes hereof, (i) a “Qualifying Termination” shall mean a termination of a Special Severance Executive’s employment with the Company either (x) by the Company without Cause
(A) within the two (2) year period commencing on the date of the occurrence of an Acceleration Event or (B) prior to the occurrence of an Acceleration Event and either (1) following the public announcement of the transaction or
event which ultimately results in such Acceleration Event or (2) at the request of a party to, or participant in, the transaction or event which ultimately results in an Acceleration Event; or (y) by a Special Severance Executive for Good
Reason within the two (2) year period commencing with the date of the occurrence of an Acceleration Event and (ii) a determination by a Special Severance Executive that he or she has “Good Reason” hereunder shall be final and
binding on the parties hereto unless the Company can establish by a preponderance of the evidence that “Good Reason” does not exist. 
  

	5.	Severance Benefits 

 Band A Benefits 

Severance Benefits for Special Severance Executives (i) in Band A at the time of a Qualifying Termination or at any time during the
two (2) year period immediately preceding the Acceleration Event or (ii) designated as a covered employee in Band A in accordance with Section 2 hereof: 
  

	 	•	 	 Accrued Rights - The Special Severance Executive’s base salary through the date of termination of employment, any annual bonus earned but unpaid
as of the date of termination for any previously completed fiscal year, reimbursement for any unreimbursed business expenses properly incurred by the Special Severance Executive in accordance with Company policy prior to the date of the Special
Severance Executive’s termination of employment and such employee benefits, if any, as to which the Special Severance Executive may be entitled under the employee benefit plans of the Company, including without limitation, the payment of any
accrued or unused vacation under the Company’s vacation policy. 

  
 3 

	 	•	 	 Severance Pay – The sum of (x) three (3) times the current annual base salary rate paid or in effect (whether or not deferred) with
respect to the Special Severance Executive at the time of the Special Severance Executive’s termination of employment, and (y) three (3) times the target annual bonus with respect to the Special Severance Executive at the time of the
Special Severance Executive’s termination of employment. 

  

	 	•	 	 Benefits and Perquisites 

 > Continued health and life insurance benefits for a three (3) year period following the Special Severance Executive’s termination of employment at the same cost to the Special Severance
Executive, and at the same coverage levels, as provided to the Special Severance Executive (and the Special Severance Executive’s eligible dependents) immediately prior to his or her termination of employment. 

> Payment of a lump sum amount (“Pension Lump Sum Amount”) equal to the difference between (i) the total lump sum value
of the Special Severance Executive’s pension benefit under the Exelis Inc. Salaried Retirement Plan and, as applicable, Exelis Inc. Excess Pension Plan IA, Exelis Inc. Excess Pension Plan IB, Exelis Inc. Excess Pension Plan IIA, and/or Exelis
Inc. Excess Pension Plan IIB or any successor plan; provided that the benefits under such successor plan is no less favorable than the benefits under the plans set forth herein (or corresponding pension arrangements outside the United States)
(“Pension Plans”) as of the Special Severance Executive’s termination of employment and (ii) the total lump sum value of the Special Severance Executive’s pension benefit under the Pension Plans after crediting an additional
three (3) years of age and three (3) years of eligibility and benefit service to the Special Severance Executive and applying the highest annual base salary rate and highest bonus determined above under “Severance Pay” with
respect to each of the additional three (3) years of service so credited for purposes of determining Final Average Compensation under the Pension Plans. The above total lump sum values shall be determined in the manner provided in the Excess
Pension Plans of the Company for determination of lump sum benefits upon the occurrence of an Acceleration Event, as defined in said Plans. This provision shall apply to any Special Severance Executive having a pension benefit under any of the
Pension Plans as of the Special Severance Executive’s termination of employment. 
 > Crediting of an additional three
(3) years of age and three (3) years of eligibility service for purposes of the Company’s retiree health and retiree life insurance benefits. This provision shall apply to any Special Severance Executives covered under such benefits
any time during the three (3) year period immediately preceding the Special Severance Executive’s termination of employment. 
 > Payment of a lump sum amount (“Savings Plan Lump Sum Amount”) equal to three (3) times the following amount: the highest annual base salary rate determined above under “Severance
Pay” times the highest percentage rate of Company Contributions (not to exceed three and one-half percent (3 1/2%) with respect to the Special Severance Executive under the Exelis Inc. Investment and Savings Plan for Salaried Employees and/or
the Exelis Inc. Excess Savings Plan (or corresponding savings plan arrangements outside the United States) (“Savings Plans”) (including matching contributions and floor contributions) at any time during the three (3) year period
immediately preceding the Special Severance Executive’s termination of 

  
 4 

 
employment or the three (3) year period immediately preceding the Acceleration Event. This provision shall apply to any Special Severance Executive who is a member of any of the Savings
Plans at any time during such three (3) year period. 
  

	 	•	 	 Outplacement – Outplacement services for one (1) year. 

Band B Benefits 

Severance Benefits for Special Severance Executives (i) in Band B at the time of a Qualifying Termination or at any time during the
two (2) year period immediately preceding the Acceleration Event or (ii) designated as a covered employee in Band B in accordance with Section 2 hereof; provided, that a Special Severance Executive who is in Band B at the time of a
Qualifying Termination but was in Band A anytime during the two (2) year period immediately preceding the Acceleration Event shall be entitled to Severance Benefits as a Special Severance Executive in Band A and shall not be entitled to the
Severance Benefits set forth below: 
  

	 	•	 	 Accrued Rights - The Special Severance Executive’s base salary through the date of termination of employment, any annual bonus earned but unpaid
as of the date of termination for any previously completed fiscal year, reimbursement for any unreimbursed business expenses properly incurred by the Special Severance Executive in accordance with Company policy prior to the date of the Special
Severance Executive’s termination of employment and such employee benefits, if any, as to which the Special Severance Executive may be entitled under the employee benefit plans of the Company, including without limitation, the payment of any
accrued or unused vacation under the Company’s vacation policy. 

  

	 	•	 	 Severance Pay – The sum of (x) two (2) times the current annual base salary rate paid or in effect (whether or not deferred) with
respect to the Special Severance Executive at the Special Severance Executive’s termination of employment, and (y) two (2) times the target annual bonus with respect to the Special Severance Executive at the time of the Special
Severance Executive’s termination of employment. 

  

	 	•	 	 Benefits and Perquisites 

 > Continued health and life insurance benefits for a two year period following the Special Severance Executive’s termination of employment at the same cost to the Special Severance Executive, and
at the same coverage levels, as provided to the Special Severance Executive (and the Special Severance Executive’s eligible dependents) immediately prior to his or her termination of employment. 

> Payment of a lump sum amount (“Pension Lump Sum Amount”) equal to the difference between (i) the total lump sum value
of the Special Severance Executive’s pension benefit under the Exelis Inc. Salaried Retirement Plan and, as applicable, Exelis Inc. Excess Pension Plan IA, Exelis Inc. Excess Pension Plan IB, Exelis Inc. Excess Pension Plan IIA, and/or Exelis
Inc. Excess Pension Plan IIB or any successor plan; provided that the benefits under such successor plan is no less favorable than the benefits under the plans set forth herein (or corresponding pension arrangements outside the United States)
(“Pension Plans”) as of the Special Severance Executive’s termination of employment and (ii) the total lump sum value of the Special Severance Executive’s pension benefit under the Pension Plans after crediting an

  
 5 

 
additional two (2) years of age and two (2) years of eligibility and benefit service to the Special Severance Executive and applying the highest annual base salary rate and highest
bonus determined above under “Severance Pay” with respect to each of the additional two (2) years of service so credited for purposes of determining Final Average Compensation under the Pension Plans. The above total lump sum values
shall be determined in the manner provided in the Excess Pension Plans of the Company for determination of lump sum benefits upon the occurrence of an Acceleration Event, as defined in said Plans. This provision shall apply to any Special Severance
Executive having a pension benefit under any of the Pension Plans as of the Special Severance Executive’s termination of employment. 
 > Crediting of an additional two (2) years of age and two (2) years of eligibility service for purposes of the Company’s retiree health and retiree life insurance benefits. This
provision shall apply to any Special Severance Executives covered under such benefits any time during the three (3) year period immediately preceding the Special Severance Executive’s termination of employment. 

> Payment of a lump sum amount (“Savings Plan Lump Sum Amount”) equal to two (2) times the following amount: the
highest annual base salary rate determined above under “Severance Pay” times the highest percentage rate of Company Contributions (not to exceed three and one-half percent (3 1/2%)) with respect to the Special Severance Executive under the
Exelis Inc. Investment and Savings Plan for Salaried Employees and/or the Exelis Inc. Excess Savings Plan (or corresponding savings plan arrangements outside the United States) (“Savings Plans”) (including matching contributions and floor
contributions) at any time during either the three (3) year period immediately preceding the Special Severance Executive’s termination of employment or the three (3) year period immediately preceding the Acceleration Event. This
provision shall apply to any Special Severance Executive who is a member of any of the Savings Plans at any time during such three (3) year period. 
  

	 	•	 	 Outplacement – Outplacement services for one year. 

 General 
 With respect to the provision of benefits and perquisites
described above during the above described respective three and two year periods, if, for any reason at any time the Company is unable to treat the Special Severance Executive as being eligible for ongoing participation in any Company employee
benefit plans or perquisites in existence immediately prior to the termination of employment of the Special Severance Executive, and if, as a result thereof, the Special Severance Executive does not receive a benefit or perquisite or receives a
reduced benefit or perquisite, the Company shall provide such benefits or perquisites by making available equivalent benefits or perquisites from other sources in a manner consistent with Section 15 below. 

Notwithstanding any other provision of the Plan to the contrary, all prior service and participation by a Special Severance Executive
with the Predecessor Corporation shall be credited in full towards a Special Severance Executive’s service and participation with the Company. 

  
 6 

	6.	Form of Payment of Severance Pay and Lump Sum Payments 

 Severance Pay shall be paid in cash, in non-discounted equal periodic installment payments corresponding to the frequency and duration of the severance payments that the Special Severance Executive would
have been entitled to receive from the Company as a normal severance benefit in the absence of the occurrence of an Acceleration Event. The Pension Lump Sum Amount and the Savings Plan Lump Sum Amount shall be paid in cash within thirty
(30) calendar days after the date the employment of the Special Severance Executive terminates. 
  

	7.	Termination of Employment — Other 

 The Severance Benefits shall only be payable upon a Special Severance Executive’s termination of employment due to a Qualifying Termination; provided, that if, following the occurrence of an
Acceleration Event, a Special Severance Executive is terminated due to the Special Severance Executive’s death or disability (as defined in the long-term disability plan in which the Special Severance Executive is entitled to participate
(whether or not the Special Severance Executive voluntarily participates in such plan)) and, at the time of such termination, the Special Severance Executive had grounds to resign with Good Reason, such termination of employment shall be deemed to
be a Qualifying Termination. 
  

	8.	Administration of Plan 

 This
Plan shall be administered by the Company, who shall have the exclusive right to interpret this Plan, adopt any rules and regulations for carrying out this Plan as may be appropriate and decide any and all matters arising under this Plan, including
but not limited to the right to determine appeals. Subject to applicable Federal and state law, all interpretations and decisions by Exelis shall be final, conclusive and binding on all parties affected thereby. 

Notwithstanding the preceding paragraph, following an Acceleration Event, any controversy or claim arising out of or relating to this
Plan, or the breach thereof, shall be settled by arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules and the entire cost thereof shall be borne by the Company. The location of the arbitration
proceedings shall be reasonably acceptable to the Special Severance Executive. Judgment on the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof. The Company shall pay all legal fees, costs of litigation,
prejudgment interest, and other expenses which are incurred in good faith by the Special Severance Executive as a result of the Company’s refusal to provide any of the Severance Benefits to which the Special Severance Executive becomes entitled
under this Plan, or as a result of the Company’s (or any third party’s) contesting the validity, enforceability, or interpretation of this Plan, or as a result of any conflict between the Special Severance Executive and the Company
pertaining to this Plan. The Company shall pay such fees and expenses from the general assets of the Company. 
  

	9.	Termination or Amendment 

 Exelis
may terminate or amend this Plan (“Plan Change”) at any time except, that following the occurrence of (i) an Acceleration Event or (ii) a Potential Acceleration Event, no Plan Change that would adversely affect any Special
Severance Executive may be made without 

  
 7 

 
the prior written consent of such Special Severance Executive affected thereby; provided, however, that (ii) above shall cease to apply if such Potential Acceleration Event does not result
in the occurrence of an Acceleration Event. 
  

	10.	Offset 

 Any Severance Benefits
provided to a Special Severance Executive under this Plan shall be offset in a manner consistent with Section 15 by reducing (x) any Severance Pay hereunder by any severance pay, salary continuation pay, termination pay or similar pay or
allowance and (y) any other Severance Benefits hereunder by corresponding employee benefits, perquisites or outplacement services, which the Special Severance Executive receives or is entitled to receive, (i) under the Exelis Inc. Senior
Executive Severance Pay Plan; (ii) pursuant to any other Company policy, practice, program or arrangement; (iii) pursuant to any Company employment agreement or other agreement with the Company; or (iv) by virtue of any law, custom or
practice excluding, however, any unemployment compensation in the United States, unless the Special Severance Executive voluntarily expressly waives (which the Special Severance Executive shall have the exclusive right to do) in writing any such
respective entitlement. 
  

	11.	Excise Tax 

 In the event that it
shall be determined that any Payment would constitute an “excess parachute payment” within the meaning of Section 280G of the Code, then the aggregate of all Payments shall be reduced so that the Present Value of the aggregate of all
Payments does not exceed the Safe Harbor Amount; provided, however, that no such reduction shall be effected, if the Net After-tax Benefit to Special Severance Executive of receiving all of the Payments exceeds the Net After-tax Benefit to Special
Severance Executive resulting from having such Payments so reduced. In the event a reduction is required pursuant hereto, the order of reduction shall be first all cash payments on a pro rata basis, then any equity compensation on a pro rata basis,
and lastly medical and dental coverage. 
 For purposes of this Section 11, the following terms have the following
meanings: 
 (i) “Net After-tax Benefit” shall mean the Present Value of a Payment net of all federal state and local
income, employment and excise taxes imposed on Special Severance Executive with respect thereto, determined by applying the highest marginal rate(s) applicable to an individual for Special Severance Executive’s taxable year in which the Change
in Control occurs. 
 (ii) “Payment” means any payment or distribution or provision of benefits by the Company to or
for the benefit of Special Severance Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, but determined without regard to any reductions required by this Section 11.

 (iii) “Present Value” shall mean such value determined in accordance with Section 280G(d)(4) of the Code.

 (iv) “Safe Harbor Amount” shall be an amount expressed in Present Value which maximizes the aggregate Present Value
of Payments without causing any Payment to be subject to excise tax under Section 4999 of the Code or the deduction limitation of Section 280G of the Code. 

  
 8 

 All determinations required to be made under this Section 11, including whether and
when a reduction is required and the amount of such reduction and the assumptions to be utilized in arriving at such determination, shall be made by a nationally recognized accounting firm mutually agreed to by the Special Severance Executive and
the Company (the “Accounting Firm”) which shall provide detailed supporting calculations both to the Company and the Special Severance Executive within ten (10) business days of the receipt of notice from the Special Severance
Executive that there has been a Payment, or such earlier time as is requested by the Company; provided that for purposes of determining the amount of any reduction, the Special Severance Executive shall be deemed to pay federal income tax at the
highest marginal rates applicable to individuals in the calendar year in which any such payment is required to be made. 
 All
fees and expenses of the Accounting Firm shall be borne solely by the Company. If the Accounting Firm determines that no excise tax is payable by the Special Severance Executive, it shall so indicate to the Special Severance Executive in writing.
Any determination by the Accounting Firm shall be binding upon the Company and the Special Severance Executive. 
  

	12.	Miscellaneous 

 The Special
Severance Executive shall not be entitled to any notice of termination or pay in lieu thereof. 
 Severance Benefits under this
Plan are paid entirely by the Company from its general assets. 
 This Plan is not a contract of employment, does not guarantee
the Special Severance Executive employment for any specified period and does not limit the right of the Company to terminate the employment of the Special Severance Executive at any time. 

If a Special Severance Executive should die while any amount is still payable to the Special Severance Executive hereunder had the
Special Severance Executive continued to live, all such amounts shall be paid in accordance with this Plan to the Special Severance Executive’s designated heirs or, in the absence of such designation, to the Special Severance Executive’s
estate. 
 The numbered section headings contained in this Plan are included solely for convenience of reference and shall not
in any way affect the meaning of any provision of this Plan. 
 If, for any reason, any one or more of the provisions or part of
a provision contained in this Plan shall be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Plan not held so invalid,
illegal or unenforceable, and each other provision or part of a provision shall to the full extent consistent with law remain in full force and effect. 

  
 9 

 The Plan shall be governed by and construed in accordance with the laws of the State of New
York without regard to the conflicts of laws provisions thereof. 
 The Plan shall be binding on all successors and assigns of
the Exelis Inc. and a Special Severance Executive. 
  

	13.	Notices 

 Any notice and all
other communication provided for in this Plan shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three (3) days after it has been mailed by United States registered mail, return
receipt requested, postage prepaid, addressed to the respective addresses set forth below, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be
effective only upon receipt. 
 If to the Company: 
 Exelis Inc. 
 1650 Tysons Boulevard, Suite 1700 

McLean, Virginia 22102 
 Attention: General Counsel 
 If to Special Severance Executive: 

To the most recent address of Special Severance Executive set forth in the personnel records of the Company. 

 

	14.	Adoption Date 

 This Plan was
initially adopted by Exelis Inc. on October 31, 2011 (“Adoption Date”) and does not apply to any termination of employment which occurred or which was communicated to the Special Severance Executive prior to the Adoption Date.

  

	15.	Section 409A 

 This Plan is
intended to comply with Section 409A of the Code and will be interpreted in a manner intended to comply with Section 409A of the Code. Notwithstanding anything herein to the contrary, (i) if at the time of the Special Severance
Executive’s termination of employment with the Company the Special Severance Executive is a “specified employee” as defined in Section 409A of the Code (and any related regulations or other pronouncements thereunder) and the
deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in order to prevent any accelerated or additional tax under Section 409A of the Code, then the
Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to the Special Severance Executive) until the date that is six months
following the Special Severance Executive’s termination of employment with the Company (or the earliest date as is permitted under Section 409A of the Code), at which 

  
 10 

 
point all payments deferred pursuant to this Section 15 shall be paid to the Special Severance Executive in a lump sum and (ii) if any other payments of money or other benefits due
hereunder could cause the application of an accelerated or additional tax under Section 409A of the Code, such payments or other benefits shall be deferred if deferral will make such payment or other benefits compliant under Section 409A
of the Code, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Company, that does not cause such an accelerated or additional tax. To the extent any reimbursements or in-kind
benefits due under this Plan constitute “deferred compensation” under Section 409A of the Code, any such reimbursements or in-kind benefits shall be paid in a manner consistent with Treas. Reg. Section 1.409A-3(i)(1)(iv). Each
payment made under this Plan shall be designated as a “separate payment” within the meaning of Section 409A of the Code. The Company shall consult with Special Severance Executives in good faith regarding the implementation of the
provisions of this section; provided that neither the Company nor any of its employees or representatives shall have any liability to Special Severance Executives with respect thereto. 

  
 11Fourth Amendment to Bromfenac License Agreement

 Exhibit 10.39 
 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT MARKED WITH [***] HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES
EXCHANGE ACT OF 1934, AS AMENDED. 
 FOURTH AMENDMENT TO BROMFENAC LICENSE AGREEMENT 

This Fourth Amendment (the “Fourth Amendment”) is made this 26 day of March, 2012 (the “Effective Date”), by and
between ISTA Pharmaceuticals, Inc., a Delaware corporation (“ISTA”), and Senju Pharmaceutical Co., Ltd., a legal entity organized and existing under the laws of Japan (“Senju”); 

WHEREAS, ISTA and Senju are parties to a license agreement dated March 7, 2002, as amended by the Amendment To Bromfenac License
Agreement dated August 13, 2002, the Second Amendment To Bromfenac License Agreement dated May 31, 2006, and the Third Amendment to Bromfenac License Agreement dated February 16, 2010 (collectively, the “License Agreement”); and

 WHEREAS, ISTA and Senju are parties to that certain Settlement Agreement and Release dated March 26 2012 (the
“Settlement Agreement”); and 
 WHEREAS, ISTA and Senju desire to further amend the provisions of the License
Agreement in accordance with the terms of the Settlement Agreement; 
 NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, ISTA and Senju herby agree that: 
  

	 	1.	On the Effective Date, ISTA shall (i) pay to Senju Twenty Four Million United States Dollars (US$24,000,000) as the Royalty Payment (as such term is defined in the
Settlement Agreement). Senju and ISTA agree and acknowledge that the Royalty Payment shall be paid as a royalty for Net Sales during October 1, 2009 through December 31, 2011. ISTA shall pay the Royalty Payment by wire transfer, and any related wire
transfer fees, to the following bank account designated and maintained by Senju: 

 Name of Bank: [***] 

Name of Branch: [***] 
 Bank Address: [***] 
 Account Number: [***] 

Name of Account: Senju Pharmaceutical Co., Ltd. 

SWIFT Code: [***] 
 and (ii) provide Senju with a detailed report with supporting documentation stating the total quantities of Preparation sold by product, gross and Net Sales of the Preparation on a quarterly basis, from
October 1, 2009 through December 31, 2011, pursuant to paragraphs 5.01, 5.03 and 5.04 of the License Agreement. 
  

	 	2.	Effective with respect to running royalties owed Senju resulting from Net Sales made on or after January 1, 2012, paragraph 4.01 of the License Agreement shall be
amended to read in its entirety: 

 “(i) Except as set forth in paragraph 4.01(ii), in
consideration of all of the rights granted during and under the License Agreement, ISTA shall pay SENJU as running royalties a sum corresponding to [***] percent ([***]%) of the Net Sales of any Preparation commercialized for sale on or before the
date of this Fourth Amendment and not covered by a Valid Claim under United States Patent No. 8,129,431 or any other of the Patent Rights in the Territory. SENJU acknowledges that ISTA’s current Preparation BROMDAY® is not covered by a Valid Claim under United States Patent No. 8,129,431 or any other of the Patent Rights in the
Territory. 
 (ii) In consideration of the Patent Rights, Technical Information & Know-How and all
rights granted during and under the License Agreement, ISTA shall pay SENJU as running royalties a sum corresponding to [***] percent ([***]%) of the Net Sales of any Preparation which is covered by a Valid Claim under United States Patent No.
8,129,431 or any other of the Patent Rights in the Territory. ISTA acknowledges that ISTA’s Preparation under development designated as PROLENSATM, is currently covered by a Valid Claim under United States Patent No. 8,129,431. Except as set 

  
 [***]: CONFIDENTIAL
PORTIONS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 

  
 2 

 
forth in paragraph 4.01(i), in the event PROLENSATM or
other Preparation is not covered by a Valid Claim, ISTA shall pay as running royalties a sum corresponding to a reduced step-down royalty of [***] percent ([***]%) of the Net Sales of such Preparation in consideration of all rights granted during
and under this License Agreement. For the sake of clarity, ISTA acknowledges that this paragraph 4.01 of the License Agreement is amended in order to clarify and restate an agreement by ISTA and SENJU that the obligation to make royalty payments
under the License Agreement, as amended by the Fourth Amendment, is in compliance with the United States Supreme Court decision in Brulotte v. Thys, and with any similar decision, rule or regulation, and ISTA agrees and covenants forever not
to sue or assert any claim whatsoever against SENJU on the ground that the Brulotte decision, or any similar decision, rule or regulation, prohibits or allegedly makes illegal and unenforceable payment of royalties to SENJU under the License
Agreement. 
 (iii) If the Net Sales in any year decreases more than [***] percent ([***]%) compared to the preceding year due
to the commercialization of a generic product equivalent to the Preparation in the Territory, the running royalty rate shall decrease and ISTA shall pay SENJU as running royalties a sum corresponding to [***] percent ([***]%) of the Net Sales of the
Preparation during the remaining term of the License Agreement. The foregoing shall be subject to the clarification in paragraph 5 of the Second Amendment to Bromfenac License Agreement dated May 31, 2006. For the sake of clarity, this paragraph
4.01(iii) shall not affect the application of the [***]% royalty rate as set forth in paragraph 4.01(i) above to any Preparation commercialized for sale on or before the date of the Fourth Amendment and not covered by a Valid Claim under the Patent
Rights. 
 (iv) For purposes of this paragraph 4.01, “Valid Claim” means a claim (a) of any issued, unexpired patent
that has not been revoked or held unenforceable or invalid by a final decision of a court or governmental agency of competent jurisdiction from which no appeal can be taken, or with respect to which an appeal is not taken within

  
 [***]: CONFIDENTIAL
PORTIONS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 

  
 3 

 
the time (including any extensions) allowed for appeal, and that has not been disclaimed or admitted to be invalid or unenforceable through reissue, disclaimer or otherwise, or (b) of any patent
application that has been pending less than four (4) years from the earliest date on which such patent application claims priority and which claim has not been irretrievably cancelled, withdrawn or abandoned.” 

 

	 	3.	Unless stated herein, all other terms and conditions of the License Agreement shall remain unchanged. 

 

	 	4.	This Fourth Amendment, taken together with the License Agreement and the Settlement Agreement, represents the entire agreement of the parties and shall supersede any
and all previous contracts, arrangements or understandings between the parties with respect to the subject matter hereof. 

  

	 	5.	This Fourth Amendment may be amended at any time only by mutual signed written agreement of the parties hereto. 

 

	 	6.	This Fourth Amendment shall be executed in duplicates, each of which so executed will be deemed to be an original and such counterparts together will constitute one and
the same agreement. 

 IN WITNESS WHEREOF, this Fourth Amendment has been entered into as of the
date first set forth above. 
  

											
	ISTA PHARMACEUTICALS, INC.	  		  	SENJU PHARMACEUTICAL CO., LTD.	  	
						
	By:	  	 /s/ Lauren Silvernail
	  		  	By:	  	 /s/ Shuhei Yoshida
	  	
	Name: Lauren Silvernail	  		  	Name: Shuhei Yoshida	  	
	Title: CFO & V.P. Corporate Development	  		  	Title: Executive Vice-President	  	

  
 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]